版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
pharmacologyGeneralintroductionDrugsactingonefferentnervoussystemDrugsactingoncentralnervoussystemDrugsactingoncardiovascularsystemDrugsactingonvisceraChemotherapeuticagentspharmacologyGeneralintroductiChapter5IntrductiontoPharmacology
ofEfferentNervousSystemZhangBinInstituteofPharmacologySchoolofMedicineShandongUniversityChapter5IntrductiontoPharOrganizationofNervoussystemOrganizationofNervoussystemefferentnervoussystem(ENS)
autonomicnervoussystem(vegetativenervoussystem)somaticmotornervoussystem
efferentnervoussystem(ENS)
Efferentneuronsoftheautonomic
nervoussystemEfferentneuronsoftheautonoClassificationofENSaccordingtothereleasedneurotransmitters
cholinergicnerve:acetylcholine(Ach)
noradrenergicnerve:noradrenaline(NA)
ClassificationofENSaccordin03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropineClassificationofENSParasympatheticnerveCentralnervoussystem
Achskeletalmuscle
AchNA
AchAchsweatglands
Ach
AchAchadrenalmedullasomaticmotornerve
sympatheticnerveglands,smoothmuscle,heartheart,vessel,smoothmuscleClassificationofENSParasympSection1Neurotransmitterand
ReceptorofENS
NeurotransmitterofENSThereceptorsofENSSection1Neurotransmitte一.NeurotransmitterofENS1.Developmentofneurotransmittertheory100yearsagoChemicaltransmissionelectronictransmission1946VonEulerNA(noradrenaline)1921loewidoublefrogheartexperiment1926DaleAch(acetylcholine)一.NeurotransmitterofENS1.De03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropine2.Biosynthesis,storage,releaseandterminationofneurotransmittersAch(acetylcholine)NA(noradrenaline)2.Biosynthesis,storage,releainhibitorinhibitor03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropine2.Biosynthesis,storage,releaseandterminationofneurotransmitters
(1)Biosynthesischoline+acetylcoenzymeAAchtyrosinedopaDANAcholineacetylaseTHDDDH2.Biosynthesis,storage,relea(2)Storage
+ATP+proteinstoreinvesicles
AchNA(2)StorageAchNA(3)releaseexocytosisquantalrealeasecotransmission(3)releaseexocytosis(4)Termination
Ach:
acetylcholinesterase(AchE)insynapseNA:
uptake1(neuronaluptake)75%-90%storageinvesicles\MAOuptake2(non-neuronaluptake)COMT\MAO
(4)Termination
Ach:acetylchol二.ThereceptorsofENS
Classification,DistributionandEffect二.ThereceptorsofENSClassiCholinereceptors(Cholinoceptors)M-R:
muscarineN-R:nicotine
Cholinereceptors(Cholinocep03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropineCholinoceptorsM-R:M1-R:ganglion,CNSM2-R:heart,presynapticsites(negativefeedback),CNSM3-R:exocrineglands,smoothmuscle,endothelium,CNSM4–R:exocrineglands,smoothmuscle,CNSM5-R:CNSCholinoceptorsM-R:CholinoceptorsN-R:nicotineNM-R:skeletalmuscle
NN-R:ganglionandCNSCholinoceptorsN-R:nicotinadrenoceptor:NAAD
α-Rα1-R:
postsynapticeffectorcells
(especiallysmoothmuscle)α2-R:
presynapticnerveterminals(negativefeedback),platelet,smoothmuscle,lipocytesadrenoceptor:NAADα-Radrenoceptorβ-Rβ1-R:postsynapticeffectorcells,(especiallyheart,lipocytes,)
presynapticnerveterminalsβ2-R:postsynapticeffectorcells,(especiallysmoothmuscle)β3-R:postsynapticeffectorcells,
(especiallylipocytes)adrenoceptorβ-R03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropineClassificationofreceptoraccordingtotheirstructureG-protein-coupledreceptor:
-R,-R,M-R,DA-R,5-HT-RLigand-gatedreceptors
N-RClassificationofreceptoraccStructureofG-protein-coupledReceptorStructureofG-protein-coupledMolecularMechanismofGq-protein-coupledReceptorMolecularMechanismofGq-protMolecularMechanismofGi/s-protein-coupledReceptorMolecularMechanismofGi/s-prStructureofligand-gatedionchannelReceptorStructureofligand-gatedionMolecularMechanismofligand-gatedionchannelreceptorMolecularMechanismofligand-1.Cholinoceptors
M-R:G-protein-coupledreceptor
M1-R:Gq-protein-coupledreceptor
M2-R-Gi-protein-coupledreceptor
N-R:ligand-gatedionchannelreceptor2.
adrenoceptor:
G-protein-coupledreceptorα1–R:Gq-protein-coupledreceptorα2–R:Gi-protein-coupledreceptorβ-R:Gs-protein-coupled
receptor1.CholinoceptorsMolecularMechanismofReceptor
N-RNa+,K+,
Ca2+G-protein-coupledreceptor
ligand-gatedreceptor:(-)
PKA
cAMPM1-R
M2-R
GqGiK+,
Ca2+(-)AC
cAMPPLC
IP3DAGα1
-R
α2
-R
β-R(+)
AC
(-)
AC
GiGqPLC,PLA2,PLD
GscAMP(-)
PKA
(+)
PKA
Ca2+(+)
PKCMolecularMechanismofReceptoterminologyadrenergicadrenergicreceptorcholinergiccholinergicreceptorpostsynapticreceptorpresynapticreceptorterminologyadrenergicSection2
Thephysiological
actionsofENSCo-innervationandDominantTheorySympatheticactions:
fightandflightresponseParasympatheticactions:
restanddigestresponseSection2
ThephysiologicalacSection3Thebasicmechanismsof
actionsofENSdrugs
1.Directactionofreceptors
agonistblocker(antagonist)2.lnfluenceofneurotransmitters
biosynthesisreleasestorageconversionSection3Thebasicmechanisms
Section4Theclassificationofthe
ENSdrugs
Section4Theclassification(三)抗膽堿酯酶藥(三)抗膽堿酯酶藥Chapter6parasympathomimeticsCholinoceptoragonists(cholinomimetics)Anticholinesteraseagents(cholinesterase-inhibitingdrugs)DrugsofenhancersofAChreleaseChapter6parasympathomimeticsCholinoceptorAgonists
M-Ragonists:
Cholineesters:acetylcholine(ACh)
alkaloids:pilocarpineN-Ragonists:
nicotine
CholinoceptorAgonists
M-RagoSection1M-Ragonists
Acetylcholine(ACh)1.unstable2.lowselectivity3.administrationrouteSection1M-RagonistsAcety[Pharmacologicalactions]DirectlyactivateM-R,N-Rmuscarinicactions:smalldosenicotinicactions:largedose[Pharmacologicalactions]1.muscarinicactions:smalldose
1.cardiovascularsystemvesseldilate
a.NOrelease↑(M3R→EDRF(NO)↑→GC→cGMP↑→intracellularCa2+↓)b.NArelease↓
BP(HR)
Heartdepress:negative(chronotropic,dromotropic,inotropic)effect1.muscarinicactions:smalldo1.muscarinicactions:smalldose2.glands↑3.gastrointestinaltract:
motilityincrease,secretionstimulation4.urinarybladder:
detrusormuscle(逼尿?。ヽontraction,trigoneandsphincterrelaxation5.eye:
sphinctermuscleofiris(虹膜)contract:miosisciliarymusclecontract:nearvision1.muscarinicactions:smalldo2.nicotinicactions:largedoseNN-R:dominantnerveactionsNM
-R:skeletalmusclecontraction
2.nicotinicactions:largedose03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropine03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropinealkaloidsPilocarpine(毛果蕓香堿,匹魯卡品)Muscarine(毒蕈堿)
Arecoline
(檳榔堿)Oxotremorine(氧化震顫素)alkaloidsPilocarpine(毛果蕓香堿,匹魯卡Pilocarpine
Pharmacologicalactions:selectivelyactivateM-R
1.Eye
miosis:pupiliarysphincter
decreaseintraocularpressurespasmofaccommadation:ciliarymuscle
Pilocarpine
Pharmacologicalac03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropine03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropine2.Glandssecreteincreasingly
(sweatgland,salivarygland)3.Smoothmuscle4.Cardiovascularsystem2.GlandssecreteincreasinglClinicaluses
1.Glaucoma(青光眼)angle-closureglaucomaopen-angleglaucomaClinicaluses1.Glaucoma(青光眼)WhatisGlaucoma?increasedpressurewithintheeye.Cellsinsidetheeyeproduceaqueoushumorthatmaintainstheshapeoftheeyeandnourishesthetissuesinsidetheeye.Thebalanceoffluidproductionanddrainageisresponsibleformaintainingnormalpressurewithintheeye.Inglaucoma,thedrainbecomescloggedbuttheeyekeepsproducingfluid.Therefore,thepressureintheeyeincreases.TheincreasedpressureintheeyeactuallycancausetheeyetostretchandenlargeWhatisGlaucoma?increasedpreHowdoesGlaucomaaffecttheeye?VisionLoss.Pressuredamagetotheopticnerveanddecreasedbloodflowtotheretina,resultsinlossofvision.However,ifthepressureintheeyeremainsuncontrolled,theretinadegeneratesandvisionispermanentlylost.PermanentblindnesscanoccurwithinseveralhoursifthepressureisveryhighandtheglaucomadevelopsrapidlyPain.Humanshavenormalintraocularpressuresbetween10and20mmHg.Glaucomaoftenresultsinpressuresof20-28mmHginhumans.Thepainpersistsintheformofaconstantheadacheormigraine.Thisdiscomfortcanresultindecreasedactivity,lessdesiretoplay,irritability,ordecreasedappetiteHowdoesGlaucomaaffectthee2.iritis(虹膜炎),iridocyclitis(虹膜睫狀體炎)3.others
:drymouth2.iritis(虹膜炎),Adversereactions
AdversereactionsMuscarine(毒蕈堿)Amanitamuscaria(捕蠅蕈)Inocybe(絲蓋傘菌屬)Clitocybe(杯傘菌屬)Muscarine(毒蕈堿)AmanitamuscariaSection2N-Ragonists
——nicotineNicotine:fromtobaccoAction:NM,NN,CNSanddependence(doublephase)Tobaccopoison:
Hypertension,coronaryheartdisease,cerebrovasculardisease,cancer,AtherosclerosisSection2N-Ragonists
——niChina:Largesttobaccoproductivecountry,LargesttobaccoconsumptioncountryNosmoking!Stopsmoking!China:LargesttobaccoproductiSection3
AnticholinesteraseAgentsCholinesterase:trueCholinesterase(AChE)PseudocholinesteraseSection3
Anticholinesterase03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropineAnticholinesteraseAgents
-----indirectactingcholinomimetics
AnticholinesteraseAgents
----Classificationaccordingtostructurenon-covalentbondingagents:
Edrophoniumchloride(依酚氯銨):strongpolarity,short
tacrine(他克林):stronglipophilia,long
donepezil(多奈哌齊):stronglipophilia,longCarboxamide(氨甲酰類(lèi)):
Physostigmine(毒扁豆堿)
Pyridostigmine(吡斯的明)Demecarium(地美溴銨)rivastigmine(利凡斯的明)orgnaophosphoruscompound(有機(jī)磷化合物)Classificationaccordingtost親和力親脂性BBB維持時(shí)間依酚氯銨一般弱—短他克林較高強(qiáng)+長(zhǎng)多奈哌齊較高強(qiáng)+長(zhǎng)親和力親脂性BBB維持時(shí)間依酚氯銨一般弱—短他克林較高強(qiáng)+長(zhǎng)ClassificationaccordingtopharmacologicalpropertyReversibleAnticholinesteraseagentsirreversibleAnticholinesteraseagents
ClassificationaccordingtophMechanismsofactions:Pharmacologicalactions:
1.eye2.gastrointestinaltract(esophagus,stomach,intestine)3.motorendplate4.glands5.cardiovascularsystemMechanismsofactions:ClinicalUses
1.Myastheniagravis(重癥肌無(wú)力):NeostigminePyridostigmine(吡斯的明)Ambenoniumchloride(安貝氯胺)
ClinicalUses1.Myastheniagr03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropineClinicalUses2.Postoperativeabdominaldistension;Urinaryretention:Neostigmine3.glaucoma:Physostigmine(毒扁豆堿)Demecarium(地美溴銨)
ClinicalUses2.Poxicationofd-tubocurarine:Neostigmine,Edrophoniumchloride(依酚氯銨):5.Alzheimer’sdisease:
tacrine,donepezil,
rivastigmine,galanthamin
6.Soxicationofd-tubocurar
CommonusedagentsReversibleAnticholinesteraseagents
CommonusedagentsReversibl
Neostigmine(新斯的明)actions:1.InhibitAChE2.ActivateNM-Ronmotorendplate3.Strongeffectonskeletalmuscle4.NotintoCNS
Neostigmine(新斯的明)actions:Uses:1.Myastheniagravis:Skeletalmusclecontraction
po,sc,imiv2.Postoperativeabdominaldistension;Uoxicationofd-tubocurarineandatropine4.Supraventriculartachyarrhythmias5.GlaucomaUses:Adversereactions:
Cholinergicoverexcitation(cholinergiccrisis)Treatment:atropine
d-tubocurarine
Adversereactions:Pyridostigmine(吡斯的明)WeakerthanNeostigmineslowerthanNeostigmineLongerthanNeostigmineNotintoCNSUsedtotreatMyastheniagravisContraindication:mechanicalileus,urinaryobstructionPyridostigmine(吡斯的明)WeakerthPhysostigminecharacteristics1.Strongerthanneostigmine2.CanenterCNS3.HavenodirectactiononRPhysostigminecharacteristicsactions:1.eye2.systemicactionUses:1.Glaucoma2.Intoxicationofanticholineagents:
Atropine
TricyclicantidepressantDibenzothiazineantipsychotics
actions:Comparisontopilocarpine1.Morerapid2.Stronger3.longerComparisontopilocarpineDonepezilRivastigmineTacrine
——Alzheimer’sdiseaseDonepezilReversibleanticholinesteraseagentsneostigmine\Pyridostigmine\Ambenonium\Galanthamine:MyastheniagravisPhysostigmine\Demecarium:Glaucoma
Edrophoniumchloride:diagnostictestformyastheniagravisDonepezil\rivastigmine\Tacrine\:Alzheimer’sdiseaseReversibleanticholinesteraseIrreversibleAnticholinesteraseAgents--Organophosphates
MechanismsofintoxicationPathwayofintoxication
signsofacuteintoxication1.Mmanifestation(muscarinicexcess)2.Nmanifestation(nicotiniceffects)3.CNSeffectsChronicintoxication
IrreversibleAnticholinesteras03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropinePreventionandtreatmentof
organophosphatesintoxication
PreventionTreatmentofacuteintoxication
1.maintenanceofvitalsigns2.Decontaminationtopreventfurtherabsorption3.Symptomatictreatment1)atropine2)cholinesterasereactivator
Preventionandtreatmentof
oCholinesteraseReactivators
Pralidoximeiodide(PAM):碘解磷定Mechanismsofactiontherapeuticeffect
1.inhibitNmmanifestation——strong2.inhibitMmanifestation——weak3.CNS
碘解磷定磷?;疉ChE復(fù)合物磷?;饨饬锥ˋChECholinesteraseReactivators
PrPralidoximechloride
(PAM-Cl):氯解磷定betterwater-solubilityimandivlittleadversereactionPralidoximechloride(PAM-Cl):03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropineChapter7cholinoceptor-blockingdrugsM-RblockersN-Rblockers:NN-RblockersNM-RblockersChapter7cholinoceptor-blockiMuscariniccholinoceptor
-blockingdrugs
Atropineandatropine-likealkaloidsSyntheticatropinesubstitutesMuscariniccholinoceptor
-bloatropine-likealkaloidsandtheirresources植物主要生物堿
顛茄(atropabelladonna)莨菪堿(hyoscyamine)曼陀羅(daturastramonium)莨菪堿洋金花(datruasp)東莨菪堿
(scopolamine)莨菪(hyoscyamusniger)莨菪堿
唐古特莨菪(scopoliatangutica)山莨菪堿
(anisodamine)
樟柳堿(anisodineatropine-likealkaloidsand顛茄莨菪顛茄莨菪曼陀羅洋金花曼陀羅洋金花Atropine
pharmacologicalactions:
blockM-RblockNN-RinlargedoseAtropine
pharmacologicalactio03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropinepharmacologicalactions1.glands:
secretion↓salivary,sweat>lacrimal,respiratory>gastricacid,pancreatic,intestinaljuice2.eyes
(1)mydriasis(2)increaseintraocularpressure(3)paralysisofaccommodationpharmacologicalactions1.glan03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropine3.splanchnic
smoothmuscle:relaxation
(spasmodic)GItract,detrusormuscleofbladder:significant
Biletract,bronchial,uterine(子宮):weak3.splanchnicsmoothmuscle:r4.heart:(1)HR
Therapeuticdose:decrease
(presynapticM1blockade)Largedose:increase(blockvagaleffectonM2–R)(2)A-Vconduction:4.heart:5.vessels:dilation(inlargedose)
(1)Directeffect(2)Compensativereactionbytemperaturerise6.CNS:excitation5.vessels:dilation(inlarge03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropineOrgansensitivity:Gland>eye>splanchnicsmoothmuscle>cardiovascularsystem>CNS.Organsensitivity:ClinicalUses1.Anti-smoothmusclespasm2.
Pre-anaesthesiamedicationagent3.
Ophthalmologicaluse(1)iridocyclitis
(2)optometry
(3)examinationofretina4.Bradyarrhythmias5.
Shock(septicshock):Cautions6.IntoxicationoforganophosphateClinicalUses1.Anti-smoothmuadversereactions1.CommonSideEffectsadversereactions1.CommonSid2.AcutePoisoningminimallethaldose:adults–80~130mgchildren--10mgPrevention1.Decontamination:topreventfurtherabsorption2.Antidotes:
Parasympathomimetics3.Maintenanceofvitalsigns2.AcutePoisoningcontraindictions
Glaucomaprostatichypertrophy
contraindictionsanisodamine(654-2)
山莨菪堿Characteristicofactions1.highselectivity(smoothmuscleandvessels)2.littlesideeffect(notpassthroughBBB)Uses1.septicshock2.visceralcolics.anisodamine(654-2)
山莨菪堿Charact
Scopolamine(東莨菪堿)
[Characteristics]1.CNSactions:depression(strong)
2.peripheralactions:glands:strongothers:weakUses:1.preanaesthesiamedication2.preventionmotionsickness
3.Parkinsondisease
4.traditionalmedicineanaesthesia
Scopolamine(東莨菪堿)
[Character中藥麻醉華佗(公元141~203年)“麻沸散”
曼陀羅(洋金花)徐州醫(yī)學(xué)院附屬醫(yī)院:中藥麻醉湯(針劑)東莨菪堿中藥麻醉華佗(公元141~203年)Section2SyntheticatropinesubstitutesSyntheticMydriaticsSyntheticAntispasmaticsSelectiveM1AntagonistsSection2SyntheticatropinesSyntheticMydriaticsHomatropine(后馬托品)Tropicamide(托吡卡胺)Cyclopentolate(環(huán)噴托酯)Eucatropine(尤卡托品)SyntheticMydriaticsHomatropinComparisonofsomemydriaticsdrugsconcentration(%)mydriasisparalysisofaccommodationpeak(m)duration(d)peak(h)duration(d)atropine1.030~407~101~37~12homatropine1.0~2.040~601~20.5~11~3tropicamide0.5~1.020~400.250.5<0.25cyclopentolate0.530~50110.25~1eucatropine2.0~5.0301/12~1/4ComparisonofsomemydriaticscUses:iridocyclitis
optometry
examinationofretinaUses:SyntheticAntispasmaticsQuaternaryamines(季胺類(lèi)):
Propanthelinebromide(溴丙胺太林,普魯本辛)1.selectiveblockadeofGItract:2.ulceration,GIspasm,bladderstimulation3.neuromuscularblockaction:toxicdose4.lowBBBpermeability
SyntheticAntispasmaticsQuaterQuaternaryamines(季胺類(lèi)):Ipratropiumbromide(異丙托溴胺)1.Relievebronchospasmbyinhalation2.Uses:chronicobstructivepulmonarydisease,bronchialasthma3.ganglionicblockactionstrongerthanatropine4.lowBBBpermeabilityQuaternaryamines(季胺類(lèi)):Tertiaryamines(叔胺類(lèi)):MydriaticsAnticholinergicinCNS
Antispasmaticagents
Benactyzine(貝那替嗪,胃復(fù)康)1.Relievesmoothmusclespasm2.AntianxietyeffectTertiaryamines(叔胺類(lèi)):SelectiveM1AntagonistsPirenzepine(哌侖西平)Telenzepine(替侖西平)InhibitsecretionofgastricacidClinicaluse:pepticulcerNotintoCNSSelectiveM1AntagonistsPirenz03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropine受體亞型分布效應(yīng)N1受體N2受體M1受體M2受體M3受體神經(jīng)節(jié)腎上腺髓質(zhì)骨骼肌神經(jīng)節(jié)竇房節(jié)房室節(jié)心肌平滑肌外分泌腺神經(jīng)節(jié)除極兒茶酚胺釋放骨骼肌收縮介導(dǎo)遲發(fā)性興奮突觸后電位延緩自發(fā)除極,減慢心率減慢傳導(dǎo)速度降低收縮力收縮分泌增多受體亞型分布效應(yīng)N1受體神經(jīng)節(jié)神經(jīng)節(jié)除極受體亞型分布效應(yīng)1受體2受體1受體2受體3受體血管平滑肌生殖道泌尿道平滑肌肝臟小腸平滑肌心臟胰島細(xì)胞血管平滑肌血小板神經(jīng)末梢心臟腎小球旁器細(xì)胞平滑肌肝臟脂肪組織收縮收縮肝糖原分解松弛增強(qiáng)收縮力減少胰島素分泌收縮聚集減少去甲腎上腺素釋放興奮增加腎素分泌松弛肝糖原分解脂肪分解受體亞型分布效應(yīng)1受體血管平滑肌收縮03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropine03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropine03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropine03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropinepharmacologyGeneralintroductionDrugsactingonefferentnervoussystemDrugsactingoncentralnervoussystemDrugsactingoncardiovascularsystemDrugsactingonvisceraChemotherapeuticagentspharmacologyGeneralintroductiChapter5IntrductiontoPharmacology
ofEfferentNervousSystemZhangBinInstituteofPharmacologySchoolofMedicineShandongUniversityChapter5IntrductiontoPharOrganizationofNervoussystemOrganizationofNervoussystemefferentnervoussystem(ENS)
autonomicnervoussystem(vegetativenervoussystem)somaticmotornervoussystem
efferentnervoussystem(ENS)
Efferentneuronsoftheautonomic
nervoussystemEfferentneuronsoftheautonoClassificationofENSaccordingtothereleasedneurotransmitters
cholinergicnerve:acetylcholine(Ach)
noradrenergicnerve:noradrenaline(NA)
ClassificationofENSaccordin03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropineClassificationofENSParasympatheticnerveCentralnervoussystem
Achskeletalmuscle
AchNA
AchAchsweatglands
Ach
AchAchadrenalmedullasomaticmotornerve
sympatheticnerveglands,smoothmuscle,heartheart,vessel,smoothmuscleClassificationofENSParasympSection1Neurotransmitterand
ReceptorofENS
NeurotransmitterofENSThereceptorsofENSSection1Neurotransmitte一.NeurotransmitterofENS1.Developmentofneurotransmittertheory100yearsagoChemicaltransmissionelectronictransmission1946VonEulerNA(noradrenaline)1921loewidoublefrogheartexperiment1926DaleAch(acetylcholine)一.NeurotransmitterofENS1.De03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropine2.Biosynthesis,storage,releaseandterminationofneurotransmittersAch(acetylcholine)NA(noradrenaline)2.Biosynthesis,storage,releainhibitorinhibitor03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropine2.Biosynthesis,storage,releaseandterminationofneurotransmitters
(1)Biosynthesischoline+acetylcoenzymeAAchtyrosinedopaDANAcholineacetylaseTHDDDH2.Biosynthesis,storage,relea(2)Storage
+ATP+proteinstoreinvesicles
AchNA(2)StorageAchNA(3)releaseexocytosisquantalrealeasecotransmission(3)releaseexocytosis(4)Termination
Ach:
acetylcholinesterase(AchE)insynapseNA:
uptake1(neuronaluptake)75%-90%storageinvesicles\MAOuptake2(non-neuronaluptake)COMT\MAO
(4)Termination
Ach:acetylchol二.ThereceptorsofENS
Classification,DistributionandEffect二.ThereceptorsofENSClassiCholinereceptors(Cholinoceptors)M-R:
muscarineN-R:nicotine
Cholinereceptors(Cholinocep03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropineCholinoceptorsM-R:M1-R:ganglion,CNSM2-R:heart,presynapticsites(negativefeedback),CNSM3-R:exocrineglands,smoothmuscle,endothelium,CNSM4–R:exocrineglands,smoothmuscle,CNSM5-R:CNSCholinoceptorsM-R:CholinoceptorsN-R:nicotineNM-R:skeletalmuscle
NN-R:ganglionandCNSCholinoceptorsN-R:nicotinadrenoceptor:NAAD
α-Rα1-R:
postsynapticeffectorcells
(especiallysmoothmuscle)α2-R:
presynapticnerveterminals(negativefeedback),platelet,smoothmuscle,lipocytesadrenoceptor:NAADα-Radrenoceptorβ-Rβ1-R:postsynapticeffectorcells,(especiallyheart,lipocytes,)
presynapticnerveterminalsβ2-R:postsynapticeffectorcells,(especiallysmoothmuscle)β3-R:postsynapticeffectorcells,
(especiallylipocytes)adrenoceptorβ-R03阿托品atropine——山東大學(xué)藥理學(xué)英文課件03IntroductionAChatropineClassificationofreceptoraccordingtotheirstructureG-protein-coupledreceptor:
-R,-R,M-R,DA-R,5-HT-RLigand-gatedreceptors
N-RClassificationofreceptoraccStructureofG-protein-coupledReceptorStructureofG-protein-coupledMolecularMechanismofGq-protein-coupledReceptorMolecularMechanismofGq-protMolecularMechanismofGi/s-protein-coupledReceptorMolecularMechanismofGi/s-prStructureofligand-gatedionchannelReceptorStructureofligand-gatedionMolecularMechanismofligand-gatedionchannelreceptorMolecularMechanismofligand-1.Cholinoceptors
M-R:G-protein-coupledreceptor
M1-R:Gq-protein-coupledreceptor
M2-R-Gi-protein-coupledreceptor
N-R:ligand-gatedionchannelreceptor2.
adrenoceptor:
G-protein-coupledreceptorα1–R:Gq-protein-coupledreceptorα2–R:Gi-protein-coupledreceptorβ-R:Gs-protein-coupled
receptor1.CholinoceptorsMolecularMechanismofReceptor
N-RNa+,K+,
Ca2+G-protein-coupledreceptor
ligand-gatedreceptor:(-)
PKA
cAMPM1-R
M2-R
GqGiK+,
Ca2+(-)AC
cAMPPLC
IP3DAGα1
-R
α2
-R
β-R(+)
AC
(-)
AC
GiGqPLC,PLA2,PLD
GscAMP(-)
PKA
(+)
PKA
Ca2+(+)
PKCMolecularMechanismofReceptoterminologyadrenergicadrenergicreceptorcholinergiccholinergicreceptorpostsynapticreceptorpresynapticreceptorterminologyadrenergicSection2
Thephysiological
actionsofENSCo-innervationandDominantTheorySympatheticactions:
fightandflightresponseParasympatheticactions:
restanddigestresponseSection2
ThephysiologicalacSection3Thebasicmechanismsof
actionsofENSdrugs
1.Directactionofreceptors
agonistblocker(antagonist)2.lnfluenceofneurotransmitters
biosynthesisreleasestorageconversionSection3Thebasicmechanisms
Section4Theclassificationofthe
ENSdrugs
Section4Theclassification(三)抗膽堿酯酶藥(三)抗膽堿酯酶藥Chapter6parasympathomimeticsCholinoceptoragonists(cholinomimetics)Anticholinesteraseagents(cholinesterase-inhibitingdrugs)DrugsofenhancersofAChreleaseChapter6parasympathomime
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- GB/T 45097.3-2024智能消費(fèi)品安全第3部分:風(fēng)險(xiǎn)控制
- YC/T 398-2024煙草商業(yè)企業(yè)物流現(xiàn)場(chǎng)管理規(guī)范
- 2025版工業(yè)4.0項(xiàng)目廠房收購(gòu)合同樣本3篇
- 航空航天碳資產(chǎn)管理辦法
- 礦山工程招投標(biāo)法規(guī)實(shí)務(wù)講解
- 橋梁質(zhì)量檢測(cè)協(xié)議
- 2024年度地板企業(yè)競(jìng)業(yè)禁止協(xié)議范本3篇
- 企業(yè)重組顧問(wèn)聘用協(xié)議模板
- 私募基金資金流動(dòng)規(guī)則
- 畜牧養(yǎng)殖保證人擔(dān)保承諾書(shū)
- 湖南省益陽(yáng)市2023-2024學(xué)年高二上學(xué)期1月期末物理試題 含答案
- 銅工崗位安全操作規(guī)程(2篇)
- 擦玻璃安全責(zé)任合同協(xié)議書(shū)范本
- 2024-2025學(xué)年人教PEP版英語(yǔ)五年級(jí)上冊(cè)期末試題
- 2019水電工程探地雷達(dá)探測(cè)技術(shù)規(guī)程
- 災(zāi)難事故避險(xiǎn)自救-終結(jié)性考核-國(guó)開(kāi)(SC)-參考資料
- 室內(nèi)墻地磚鋪貼施工技術(shù)交底
- JP柜技術(shù)規(guī)范可編輯范本
- 有關(guān)中醫(yī)康復(fù)治療課件
- 江蘇省蘇州市(2024年-2025年小學(xué)五年級(jí)語(yǔ)文)統(tǒng)編版期末考試((上下)學(xué)期)試卷及答案
- 期末復(fù)習(xí)試題(試題)-2024-2025學(xué)年四年級(jí)上冊(cè)數(shù)學(xué)人教版
評(píng)論
0/150
提交評(píng)論